Shah Nimish P — SEC insider filings
SEC reporting owner CIK 1698082. 52 insider filings on record with FilingPulse; latest filed 2026-11-04.
Transaction summary — filings shown
Covers the 50 most recent of 52 filings on record, filed 2021-03-22 to 2026-11-04. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 101 legs across 38 filings — 10,392,517 shares, $141,823,993 total (shares × price as filed).
- Open-market sales (code S, non-derivative): 9 legs across 3 filings — 6,726,171 shares, $7,246,094 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 28.
- Largest priced transaction: purchase of 1,944,444 shares @ $18.00 ($34,999,992) in Lycia Therapeutics, Inc., filed 2026-10-27.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Tricida, Inc. (TCDA) | 10% owner | 20 | 46 legs · 4,528,657 sh · $46,709,158 | 3 legs · 6,451,540 sh · $3,501,547 | — |
| Lycia Therapeutics, Inc. (LYCA) | 10% owner | 4 | 12 legs · 2,078,749 sh · $38,522,394 | — | 3 |
| Apogee Therapeutics, Inc. (APGE) | Director | 6 | 1 leg · 1,750,000 sh · $29,750,000 | — | 12 |
| KalVista Pharmaceuticals, Inc. (KALV) | 10% owner | 15 | 32 legs · 1,612,229 sh · $19,435,073 | 5 legs · 214,631 sh · $3,691,148 | 1 |
| Instil Bio, Inc. (TIL) | Director | 2 | 5 legs · 300,000 sh · $6,000,000 | — | 11 |
| Oruka Therapeutics, Inc. (ORKA) | 10% owner | 1 | 5 legs · 122,882 sh · $1,407,368 | — | — |
| VistaGen Therapeutics, Inc. (VTGN) | 10% owner | 1 | — | 1 leg · 60,000 sh · $53,400 | — |
| Korsana Biosciences, Inc. (KRSA) | Director | 1 | — | — | 1 |
Insider filings — Shah Nimish P
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-11-04 | 4 | Lycia Therapeutics, Inc. (LYCA) jointly with Venrock Healthcare Capital Partners III, L.P., VHCP Co-Investment Holdings III, LLC, VHCP Management III, LLC, Venrock Healthcare Capital Partners EG, L.P., VHCP Management EG, LLC, Venrock Healthcare Capital Partners XP, L.P., VHCP Management XP, LLC, Koh Bong Y | Purchase (P): 8,305 @ $26.95 | EDGAR |
| 2026-10-30 | 4 | Lycia Therapeutics, Inc. (LYCA) jointly with Venrock Healthcare Capital Partners III, L.P., VHCP Co-Investment Holdings III, LLC, VHCP Management III, LLC, Venrock Healthcare Capital Partners EG, L.P., VHCP Management EG, LLC, Venrock Healthcare Capital Partners XP, L.P., VHCP Management XP, LLC, Koh Bong Y | Purchase (P): 10,570 @ $25.23 · Purchase (P): 4,430 @ $25.97 · Purchase (P): 1,000 @ $26.33 · Purchase (P): 8,804 @ $26.27 · Purchase (P): 200 @ $26.86 | EDGAR |
| 2026-10-27 | 4 | Lycia Therapeutics, Inc. (LYCA) jointly with Venrock Healthcare Capital Partners III, L.P., VHCP Co-Investment Holdings III, LLC, VHCP Management III, LLC, Venrock Healthcare Capital Partners EG, L.P., VHCP Management EG, LLC, Venrock Healthcare Capital Partners XP, L.P., VHCP Management XP, LLC, Koh Bong Y | Purchase (P): 24,560 @ $25.68 · Purchase (P): 28,379 @ $26.11 · Conversion (C): 4,779,793 · Purchase (P): 1,944,444 @ $18 · Purchase (P): 8,261 @ $26.97 · Purchase (P): 8,729 @ $25.84 · +3 more | EDGAR |
| 2026-10-22 | 3 | Lycia Therapeutics, Inc. (LYCA) jointly with Venrock Healthcare Capital Partners III, L.P., VHCP Co-Investment Holdings III, LLC, VHCP Management III, LLC, Venrock Healthcare Capital Partners EG, L.P., VHCP Management EG, LLC, Venrock Healthcare Capital Partners XP, L.P., VHCP Management XP, LLC, Koh Bong Y | Holdings only — no transactions reported | EDGAR |
| 2026-09-10 | 4 | Korsana Biosciences, Inc. (KRSA) | Grant/award (A): 48,445 (derivative) @ $0 | EDGAR |
| 2026-09-03 | 4 | Apogee Therapeutics, Inc. (APGE) | Disposition to issuer (D): 1,750,000 @ $135.11 · Disposition to issuer (D): 6,743,321 (derivative) @ $135.11 · Disposition to issuer (D): 47,758 (derivative) · Disposition to issuer (D): 10,370 (derivative) · Disposition to issuer (D): 14,461 (derivative) · Disposition to issuer (D): 7,657 (derivative) · +1 more | EDGAR |
| 2026-06-11 | 4 | Apogee Therapeutics, Inc. (APGE) | Grant/award (A): 7,657 (derivative) @ $0 | EDGAR |
| 2026-03-27 | 4 | KalVista Pharmaceuticals, Inc. (KALV) jointly with Venrock Healthcare Capital Partners III, L.P., VHCP Co-Investment Holdings III, LLC, VHCP Management EG, LLC, Venrock Healthcare Capital Partners EG, L.P., VHCP Management III, LLC, Koh Bong Y | Sale (S): 174,485 @ $16.95 · Sale (S): 160 @ $17.53 · Sale (S): 21,386 @ $17.76 · Sale (S): 15,417 @ $18.82 · Sale (S): 3,183 @ $19.12 | EDGAR |
| 2025-10-15 | 4 | Apogee Therapeutics, Inc. (APGE) | Purchase (P): 365,853 (derivative) @ $41.00 | EDGAR |
| 2025-06-20 | 4 | Apogee Therapeutics, Inc. (APGE) | Grant/award (A): 14,461 (derivative) @ $0 | EDGAR |
| 2025-04-11 | 4 | KalVista Pharmaceuticals, Inc. (KALV) jointly with Venrock Healthcare Capital Partners III, L.P., VHCP Co-Investment Holdings III, LLC, VHCP Management EG, LLC, Venrock Healthcare Capital Partners EG, L.P., VHCP Management III, LLC, Koh Bong Y | Purchase (P): 25,000 @ $9.42 | EDGAR |
| 2025-02-27 | 4 | Oruka Therapeutics, Inc. (ORKA) jointly with Venrock Healthcare Capital Partners III, L.P., VHCP Co-Investment Holdings III, LLC, VHCP Management EG, LLC, Venrock Healthcare Capital Partners EG, L.P., VHCP Management III, LLC, Koh Bong Y | Purchase (P): 574 @ $10.90 · Purchase (P): 9,593 @ $10.95 · Purchase (P): 8,971 @ $11.86 · Purchase (P): 14,950 @ $11.63 · Purchase (P): 88,794 @ $11.44 | EDGAR |
| 2025-02-14 | 4 | KalVista Pharmaceuticals, Inc. (KALV) jointly with Venrock Healthcare Capital Partners III, L.P., VHCP Co-Investment Holdings III, LLC, VHCP Management EG, LLC, Venrock Healthcare Capital Partners EG, L.P., VHCP Management III, LLC, Koh Bong Y | Purchase (P): 100,000 @ $9.23 · Purchase (P): 61,700 @ $9.33 | EDGAR |
| 2025-02-11 | 4 | KalVista Pharmaceuticals, Inc. (KALV) jointly with Venrock Healthcare Capital Partners III, L.P., VHCP Co-Investment Holdings III, LLC, VHCP Management EG, LLC, Venrock Healthcare Capital Partners EG, L.P., VHCP Management III, LLC, Koh Bong Y | Purchase (P): 73,649 @ $9.29 · Purchase (P): 4,137 @ $9.14 · Purchase (P): 26,703 @ $9.18 | EDGAR |
| 2025-02-03 | 4 | KalVista Pharmaceuticals, Inc. (KALV) jointly with Venrock Healthcare Capital Partners III, L.P., VHCP Co-Investment Holdings III, LLC, VHCP Management EG, LLC, Venrock Healthcare Capital Partners EG, L.P., VHCP Management III, LLC, Koh Bong Y | Purchase (P): 43,707 @ $8.76 · Purchase (P): 11,754 @ $8.89 · Purchase (P): 14,562 @ $9.22 | EDGAR |
| 2024-06-07 | 4 | Apogee Therapeutics, Inc. (APGE) | Grant/award (A): 10,370 (derivative) @ $0 | EDGAR |
| 2024-02-22 | 4 | KalVista Pharmaceuticals, Inc. (KALV) jointly with Venrock Healthcare Capital Partners III, L.P., Koh Bong Y, VHCP Co-Investment Holdings III, LLC, VHCP Management III, LLC, VHCP Management EG, LLC, Venrock Healthcare Capital Partners EG, L.P. | Purchase (P): 655,738 (derivative) @ $15.25 | EDGAR |
| 2024-02-08 | 4 | KalVista Pharmaceuticals, Inc. (KALV) jointly with Venrock Healthcare Capital Partners III, L.P., Koh Bong Y, VHCP Co-Investment Holdings III, LLC, VHCP Management III, LLC, VHCP Management EG, LLC, Venrock Healthcare Capital Partners EG, L.P. | Purchase (P): 4,474 @ $14.74 · Purchase (P): 51,827 @ $14.56 · Purchase (P): 29,747 @ $14.70 | EDGAR |
| 2024-02-01 | 4 | KalVista Pharmaceuticals, Inc. (KALV) jointly with Venrock Healthcare Capital Partners III, L.P., Koh Bong Y, VHCP Co-Investment Holdings III, LLC, VHCP Management III, LLC, VHCP Management EG, LLC, Venrock Healthcare Capital Partners EG, L.P. | Purchase (P): 88,099 @ $14.47 | EDGAR |
| 2024-01-29 | 4 | KalVista Pharmaceuticals, Inc. (KALV) jointly with Venrock Healthcare Capital Partners III, L.P., Koh Bong Y, VHCP Co-Investment Holdings III, LLC, VHCP Management III, LLC, VHCP Management EG, LLC, Venrock Healthcare Capital Partners EG, L.P. | Purchase (P): 7,030 @ $12.73 · Purchase (P): 4,174 @ $12.98 · Purchase (P): 80,600 @ $14.22 | EDGAR |
| 2024-01-24 | 4 | KalVista Pharmaceuticals, Inc. (KALV) jointly with Venrock Healthcare Capital Partners III, L.P., Koh Bong Y, VHCP Co-Investment Holdings III, LLC, VHCP Management III, LLC, VHCP Management EG, LLC, Venrock Healthcare Capital Partners EG, L.P. | Purchase (P): 67,546 @ $12.55 · Purchase (P): 10,897 @ $12.54 · Purchase (P): 20,686 @ $12.44 | EDGAR |
| 2024-01-19 | 4 | KalVista Pharmaceuticals, Inc. (KALV) jointly with Venrock Healthcare Capital Partners III, L.P., VHCP Co-Investment Holdings III, LLC, VHCP Management III, LLC, Venrock Healthcare Capital Partners EG, L.P., VHCP Management EG, LLC, Koh Bong Y | Purchase (P): 78,925 @ $12.60 · Purchase (P): 39,680 @ $12.51 · Purchase (P): 25,000 @ $12.43 | EDGAR |
| 2024-01-16 | 4 | KalVista Pharmaceuticals, Inc. (KALV) jointly with Venrock Healthcare Capital Partners III, L.P., VHCP Co-Investment Holdings III, LLC, VHCP Management III, LLC, Venrock Healthcare Capital Partners EG, L.P., VHCP Management EG, LLC, Koh Bong Y | Purchase (P): 6,647 @ $12.68 · Purchase (P): 19,599 @ $12.73 | EDGAR |
| 2024-01-10 | 4 | KalVista Pharmaceuticals, Inc. (KALV) jointly with Venrock Healthcare Capital Partners III, L.P., VHCP Co-Investment Holdings III, LLC, VHCP Management III, LLC, Venrock Healthcare Capital Partners EG, L.P., VHCP Management EG, LLC, Koh Bong Y | Purchase (P): 69,184 @ $12.44 · Purchase (P): 20,816 @ $12.56 · Purchase (P): 47,700 @ $12.67 | EDGAR |
| 2024-01-05 | 4 | KalVista Pharmaceuticals, Inc. (KALV) jointly with Venrock Healthcare Capital Partners III, L.P., VHCP Co-Investment Holdings III, LLC, VHCP Management III, LLC, Venrock Healthcare Capital Partners EG, L.P., VHCP Management EG, LLC, Koh Bong Y | Purchase (P): 17,605 @ $12.20 · Purchase (P): 41,764 @ $12.11 | EDGAR |
| 2023-12-29 | 4 | KalVista Pharmaceuticals, Inc. (KALV) jointly with Venrock Healthcare Capital Partners III, L.P., VHCP Co-Investment Holdings III, LLC, VHCP Management III, LLC, Venrock Healthcare Capital Partners EG, L.P., VHCP Management EG, LLC, Koh Bong Y | Purchase (P): 41,514 @ $11.97 · Purchase (P): 471,490 @ $12.50 · Purchase (P): 6,013 @ $12.49 | EDGAR |
| 2023-07-17 | 4 | Apogee Therapeutics, Inc. (APGE) | Purchase (P): 1,750,000 @ $17 · Grant/award (A): 47,758 (derivative) @ $0 | EDGAR |
| 2022-10-26 | 4 | Tricida, Inc. (TCDA) jointly with Venrock Healthcare Capital Partners II, L.P., VHCP Co-Investment Holdings II, LLC, VHCP Management II, LLC, Venrock Healthcare Capital Partners III, L.P., VHCP Co-Investment Holdings III, LLC, VHCP Management III, LLC, Venrock Healthcare Capital Partners EG, L.P., VHCP Management EG, LLC, Koh Bong Y | Sale (S): 2,113,948 @ $0.61 · Sale (S): 1,970,418 @ $0.57 · Sale (S): 2,367,174 @ $0.46 | EDGAR |
| 2022-10-20 | 4 | Tricida, Inc. (TCDA) jointly with Venrock Healthcare Capital Partners II, L.P., VHCP Co-Investment Holdings II, LLC, VHCP Management II, LLC, Venrock Healthcare Capital Partners III, L.P., VHCP Co-Investment Holdings III, LLC, VHCP Management III, LLC, Venrock Healthcare Capital Partners EG, L.P., VHCP Management EG, LLC, Koh Bong Y | Purchase (P): 40,400 @ $11.98 · Purchase (P): 241,366 @ $10.29 · Purchase (P): 70,100 @ $11.25 | EDGAR |
| 2022-10-17 | 4 | Tricida, Inc. (TCDA) jointly with Venrock Healthcare Capital Partners II, L.P., VHCP Co-Investment Holdings II, LLC, VHCP Management II, LLC, Venrock Healthcare Capital Partners III, L.P., VHCP Co-Investment Holdings III, LLC, VHCP Management III, LLC, Venrock Healthcare Capital Partners EG, L.P., VHCP Management EG, LLC, Koh Bong Y | Purchase (P): 4,674 @ $11.98 · Purchase (P): 170,292 @ $11.67 | EDGAR |
| 2022-10-11 | 4 | Tricida, Inc. (TCDA) jointly with Venrock Healthcare Capital Partners II, L.P., VHCP Co-Investment Holdings II, LLC, VHCP Management II, LLC, Venrock Healthcare Capital Partners III, L.P., VHCP Co-Investment Holdings III, LLC, VHCP Management III, LLC, Venrock Healthcare Capital Partners EG, L.P., VHCP Management EG, LLC, Koh Bong Y | Purchase (P): 28,900 @ $12 · Purchase (P): 80,314 @ $11.89 · Purchase (P): 25,000 @ $11.85 | EDGAR |
| 2022-10-06 | 4 | Tricida, Inc. (TCDA) jointly with Venrock Healthcare Capital Partners II, L.P., VHCP Co-Investment Holdings II, LLC, VHCP Management II, LLC, Venrock Healthcare Capital Partners III, L.P., VHCP Co-Investment Holdings III, LLC, VHCP Management III, LLC, Venrock Healthcare Capital Partners EG, L.P., VHCP Management EG, LLC, Koh Bong Y | Purchase (P): 223,100 @ $11.81 | EDGAR |
| 2022-10-03 | 4 | Tricida, Inc. (TCDA) jointly with Venrock Healthcare Capital Partners II, L.P., VHCP Co-Investment Holdings II, LLC, VHCP Management II, LLC, Venrock Healthcare Capital Partners III, L.P., VHCP Co-Investment Holdings III, LLC, VHCP Management III, LLC, Venrock Healthcare Capital Partners EG, L.P., VHCP Management EG, LLC, Koh Bong Y | Purchase (P): 168,187 @ $9.92 · Purchase (P): 268,736 @ $11.27 | EDGAR |
| 2022-09-28 | 4 | Tricida, Inc. (TCDA) jointly with Venrock Healthcare Capital Partners II, L.P., VHCP Co-Investment Holdings II, LLC, VHCP Management II, LLC, Venrock Healthcare Capital Partners III, L.P., VHCP Co-Investment Holdings III, LLC, VHCP Management III, LLC, Venrock Healthcare Capital Partners EG, L.P., VHCP Management EG, LLC, Koh Bong Y | Purchase (P): 395,614 @ $8.56 · Purchase (P): 115,000 @ $9.38 · Purchase (P): 76,600 @ $9.92 | EDGAR |
| 2022-09-07 | 4 | Tricida, Inc. (TCDA) jointly with Venrock Healthcare Capital Partners II, L.P., VHCP Co-Investment Holdings II, LLC, VHCP Management II, LLC, Venrock Healthcare Capital Partners III, L.P., VHCP Co-Investment Holdings III, LLC, VHCP Management III, LLC, Venrock Healthcare Capital Partners EG, L.P., VHCP Management EG, LLC, Koh Bong Y | Purchase (P): 63,030 @ $12.76 · Purchase (P): 150,223 @ $11.43 · Purchase (P): 473,459 @ $11.40 | EDGAR |
| 2022-09-01 | 4 | Tricida, Inc. (TCDA) jointly with Venrock Healthcare Capital Partners II, L.P., VHCP Co-Investment Holdings II, LLC, VHCP Management II, LLC, Venrock Healthcare Capital Partners III, L.P., VHCP Co-Investment Holdings III, LLC, VHCP Management III, LLC, Venrock Healthcare Capital Partners EG, L.P., VHCP Management EG, LLC, Koh Bong Y | Purchase (P): 50,000 @ $12.20 | EDGAR |
| 2022-08-02 | 4 | Tricida, Inc. (TCDA) jointly with Venrock Healthcare Capital Partners II, L.P., VHCP Co-Investment Holdings II, LLC, VHCP Management II, LLC, Venrock Healthcare Capital Partners III, L.P., VHCP Co-Investment Holdings III, LLC, VHCP Management III, LLC, Venrock Healthcare Capital Partners EG, L.P., VHCP Management EG, LLC, Koh Bong Y | Purchase (P): 18,900 @ $9.21 | EDGAR |
| 2022-07-25 | 4 | Tricida, Inc. (TCDA) jointly with Venrock Healthcare Capital Partners II, L.P., VHCP Co-Investment Holdings II, LLC, VHCP Management II, LLC, Venrock Healthcare Capital Partners III, L.P., VHCP Co-Investment Holdings III, LLC, VHCP Management III, LLC, Venrock Healthcare Capital Partners EG, L.P., VHCP Management EG, LLC, Koh Bong Y | Purchase (P): 30,000 @ $9.59 · Purchase (P): 15,000 @ $9.21 · Purchase (P): 29,199 @ $8.95 | EDGAR |
| 2022-07-20 | 4 | Tricida, Inc. (TCDA) jointly with Venrock Healthcare Capital Partners II, L.P., VHCP Co-Investment Holdings II, LLC, VHCP Management II, LLC, Venrock Healthcare Capital Partners III, L.P., VHCP Co-Investment Holdings III, LLC, VHCP Management III, LLC, Venrock Healthcare Capital Partners EG, L.P., VHCP Management EG, LLC, Koh Bong Y | Purchase (P): 100,000 @ $9.02 · Purchase (P): 25,000 @ $9.47 · Purchase (P): 25,000 @ $9.54 | EDGAR |
| 2022-07-14 | 4 | VistaGen Therapeutics, Inc. (VTGN) jointly with Venrock Healthcare Capital Partners II, L.P., VHCP Co-Investment Holdings II, LLC, VHCP Management II, LLC, Venrock Healthcare Capital Partners III, L.P., VHCP Co-Investment Holdings III, LLC, VHCP Management III, LLC, Venrock Healthcare Capital Partners EG, L.P., VHCP Management EG, LLC, Koh Bong Y | Sale (S): 60,000 @ $0.89 | EDGAR |
| 2022-07-14 | 4 | Tricida, Inc. (TCDA) jointly with Venrock Healthcare Capital Partners II, L.P., VHCP Co-Investment Holdings II, LLC, VHCP Management II, LLC, Venrock Healthcare Capital Partners III, L.P., VHCP Co-Investment Holdings III, LLC, VHCP Management III, LLC, Venrock Healthcare Capital Partners EG, L.P., VHCP Management EG, LLC, Koh Bong Y | Purchase (P): 25,000 @ $9.81 · Purchase (P): 32,856 @ $9.98 · Purchase (P): 36,717 @ $9.85 | EDGAR |
| 2022-07-06 | 4 | Tricida, Inc. (TCDA) jointly with Venrock Healthcare Capital Partners II, L.P., VHCP Co-Investment Holdings II, LLC, VHCP Management II, LLC, Venrock Healthcare Capital Partners III, L.P., VHCP Co-Investment Holdings III, LLC, VHCP Management III, LLC, Venrock Healthcare Capital Partners EG, L.P., VHCP Management EG, LLC, Koh Bong Y | Purchase (P): 55,700 @ $9.65 · Purchase (P): 32,500 @ $9.53 | EDGAR |
| 2022-06-30 | 4 | Tricida, Inc. (TCDA) jointly with Venrock Healthcare Capital Partners II, L.P., VHCP Co-Investment Holdings II, LLC, VHCP Management II, LLC, Venrock Healthcare Capital Partners III, L.P., VHCP Co-Investment Holdings III, LLC, VHCP Management III, LLC, Venrock Healthcare Capital Partners EG, L.P., VHCP Management EG, LLC, Koh Bong Y | Purchase (P): 34,366 @ $9.71 · Purchase (P): 16,546 @ $9.93 · Purchase (P): 11,958 @ $9.66 | EDGAR |
| 2022-06-24 | 4 | Tricida, Inc. (TCDA) jointly with Venrock Healthcare Capital Partners II, L.P., VHCP Co-Investment Holdings II, LLC, VHCP Management II, LLC, Venrock Healthcare Capital Partners III, L.P., VHCP Co-Investment Holdings III, LLC, VHCP Management III, LLC, Venrock Healthcare Capital Partners EG, L.P., VHCP Management EG, LLC, Koh Bong Y | Purchase (P): 142,900 @ $10.90 · Purchase (P): 200,000 @ $10.50 · Purchase (P): 149,120 @ $9.68 | EDGAR |
| 2022-06-21 | 4 | Tricida, Inc. (TCDA) jointly with Venrock Healthcare Capital Partners II, L.P., VHCP Co-Investment Holdings II, LLC, VHCP Management II, LLC, Venrock Healthcare Capital Partners III, L.P., VHCP Co-Investment Holdings III, LLC, VHCP Management III, LLC, Venrock Healthcare Capital Partners EG, L.P., VHCP Management EG, LLC, Koh Bong Y | Purchase (P): 5,951 @ $9.69 | EDGAR |
| 2022-06-14 | 4 | Tricida, Inc. (TCDA) jointly with Venrock Healthcare Capital Partners II, L.P., VHCP Co-Investment Holdings II, LLC, VHCP Management II, LLC, Venrock Healthcare Capital Partners III, L.P., VHCP Co-Investment Holdings III, LLC, VHCP Management III, LLC, Venrock Healthcare Capital Partners EG, L.P., VHCP Management EG, LLC, Koh Bong Y | Purchase (P): 58,054 @ $8.91 · Purchase (P): 50,000 @ $8.14 · Purchase (P): 10,000 @ $8.72 | EDGAR |
| 2022-06-09 | 4 | Tricida, Inc. (TCDA) jointly with Venrock Healthcare Capital Partners II, L.P., VHCP Co-Investment Holdings II, LLC, VHCP Management II, LLC, Venrock Healthcare Capital Partners III, L.P., VHCP Co-Investment Holdings III, LLC, VHCP Management III, LLC, Venrock Healthcare Capital Partners EG, L.P., VHCP Management EG, LLC, Koh Bong Y | Purchase (P): 367,813 @ $9.89 · Purchase (P): 111,111 @ $9.51 · Purchase (P): 109,100 @ $8.97 | EDGAR |
| 2022-06-06 | 4 | Tricida, Inc. (TCDA) jointly with Venrock Healthcare Capital Partners II, L.P., VHCP Co-Investment Holdings II, LLC, VHCP Management II, LLC, Venrock Healthcare Capital Partners III, L.P., VHCP Co-Investment Holdings III, LLC, VHCP Management III, LLC, Venrock Healthcare Capital Partners EG, L.P., VHCP Management EG, LLC, Koh Bong Y | Purchase (P): 61,722 @ $8.78 · Purchase (P): 37,643 @ $9.33 · Purchase (P): 91,506 @ $9.35 | EDGAR |
| 2021-03-25 | 4 | Instil Bio, Inc. (TIL) | Conversion (C): 5,100,866 · Conversion (C): 510,030 · Conversion (C): 430,431 · Conversion (C): 43,033 · Conversion (C): 480,716 · Purchase (P): 104,640 @ $20 · +9 more | EDGAR |
| 2021-03-22 | 4 | Instil Bio, Inc. (TIL) | Grant/award (A): 52,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2020-08-10 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1698082 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs